7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,884.90

-146.50

-3.63%

76,708.00

-2,152.64

-2.73%

Crude Oil Dec 26

102.95

+0.95

+0.93%

US Private Equity

10,932.82

-7.68

-0.07%

KOSDAQ - Delayed Quote KRW

Seegene, Inc. (096530.KQ)

33,250.00 -350.00 (-1.04%)

At close: 3:30:08 PM GMT+9

Loading Chart for 096530.KQ

Chart Range Bar

Interval:

In partnership with ChartIQ

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions

Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions

Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

ADLM announces 2026 Top Corporate Supporter Award recipients and thanks them for their essential backing

ADLM announces 2026 Top Corporate Supporter Award recipients and thanks them for their essential backing

Mobilize your Website

View Site in Mobile | Classic

Share by: